Long term follow-up of allogeneic stem cell transplantation in patients with myelodysplastic syndromes using busulfan, cytosine arabinoside, and cyclophosphamide.
about
Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromes.Myeloablative hematopoietic stem cell transplantation improves survival but is not curative in a pre-clinical model of myelodysplastic syndrome.Optimized Animal Model of Cyclophosphamide-induced Bone Marrow Suppression.
P2860
Long term follow-up of allogeneic stem cell transplantation in patients with myelodysplastic syndromes using busulfan, cytosine arabinoside, and cyclophosphamide.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Long term follow-up of allogen ...... inoside, and cyclophosphamide.
@en
Long term follow-up of allogen ...... inoside, and cyclophosphamide.
@nl
type
label
Long term follow-up of allogen ...... inoside, and cyclophosphamide.
@en
Long term follow-up of allogen ...... inoside, and cyclophosphamide.
@nl
prefLabel
Long term follow-up of allogen ...... inoside, and cyclophosphamide.
@en
Long term follow-up of allogen ...... inoside, and cyclophosphamide.
@nl
P2093
P2860
P356
P1476
Long term follow-up of allogen ...... binoside, and cyclophosphamide
@en
P2093
Ehab Atallah
Gail Bentley
Joseph Uberti
Judith Abrams
Lois Ayash
Voravit Ratanatharathorn
P2860
P304
P356
10.1002/AJH.21761
P577
2010-08-01T00:00:00Z